Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy

About This Study

The purpose of this research is to examine a wearable device called Apollo that emits gentle vibrations found to benefit mood, energy, and focus. We want to understand how it affects outcomes related to MDMA-assisted psychotherapy for PTSD including depression, anxiety and emotion regulation. This study will test whether regular use of the Apollo wearable improves rates of sustained symptom remission in PTSD following MDMA-assisted psychotherapy over the course of two years

Conditions Studied

Interventions

• •Apollo Wearable

Eligibility

Inclusion Criteria:

* Age 18 or over
* Completion of the MAPS MDMA-Assisted Psychotherapy for PTSD clinical trial (treatment cohort)
* completion of the MAPS MDMA-Assisted Psychotherapy for PTSD clinical trial (placebo cohort)
* enrolled in the MAPS MDMA-Assisted Psychotherapy for PTSD clinical trial, but dropped out

Exclusion Criteria:

* Unable to give adequate informed consent
* Have any current problem which, in the opinion of the investigator might interfere with participation
* Are unable to complete questionnaires written in English

Study Locations (1)